Physician profile
Nathan Lucas
NPI 1740247766
$2,261.18
in general payments reported to CMS, 2019-2025
10 companies · $740 in 2025
The $740 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $192 · 2022: $1,225 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $709 · Food and Beverage: $31.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $708.90 |
| Food and Beverage | $31.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $1,200.00 | 2022 | |
| Treace Medical Concepts, INC. | $866.50 | 2021-2025 | |
| Pfizer INC. | $51.52 | 2019 | |
| Organogenesis INC. | $34.39 | 2021 | |
| Boston Scientific Corporation | $31.13 | 2025 | Wavewriter Alpha Prime 16 |
| Paragon 28, INC. | $22.22 | 2019 | |
| Orthofix Medical, INC. | $17.92 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2022 | |
| Axogen | $12.10 | 2019 | |
| Smith+Nephew, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.